Clinical Trial

A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the interstitial concentrations using the open-flow microperfusion device and plasma pharmacokinetics following multiple doses of povorcitinib or topical ruxolitinib cream in healthy adult participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-08.
Trial Details
NCT Number NCT07588139
Lead Sponsor Incyte Corporation
Conditions Healthy Participants
Enrollment 24 participants
Start Date 2026-05-18
Primary Completion 2026-09-03 (estimated)
Study Completion 2026-09-19 (estimated)
Updated on ClinicalTrials.gov 2026-06-03